HN1998000185A - Combinaciones de estadina-eter carboxialquilico - Google Patents

Combinaciones de estadina-eter carboxialquilico

Info

Publication number
HN1998000185A
HN1998000185A HN1998000185A HN1998000185A HN1998000185A HN 1998000185 A HN1998000185 A HN 1998000185A HN 1998000185 A HN1998000185 A HN 1998000185A HN 1998000185 A HN1998000185 A HN 1998000185A HN 1998000185 A HN1998000185 A HN 1998000185A
Authority
HN
Honduras
Prior art keywords
combinations
stadine
carboxyalkyl ether
carboxyalkyl
ether
Prior art date
Application number
HN1998000185A
Other languages
English (en)
Inventor
Warner-Lambert Company Llc
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of HN1998000185A publication Critical patent/HN1998000185A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

LA PRESENTE INVENCION SE REFIERE A COMBINACIONES DE ESTADINA-ETER CARBOXIALQUILICO
HN1998000185A 1997-12-12 1998-12-09 Combinaciones de estadina-eter carboxialquilico HN1998000185A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6937597P 1997-12-12 1997-12-12

Publications (1)

Publication Number Publication Date
HN1998000185A true HN1998000185A (es) 1999-06-02

Family

ID=22088573

Family Applications (1)

Application Number Title Priority Date Filing Date
HN1998000185A HN1998000185A (es) 1997-12-12 1998-12-09 Combinaciones de estadina-eter carboxialquilico

Country Status (30)

Country Link
EP (1) EP1045691B1 (es)
JP (1) JP2002508320A (es)
KR (1) KR20010033003A (es)
AR (1) AR017851A1 (es)
AT (1) ATE285762T1 (es)
AU (1) AU754089B2 (es)
BR (1) BR9813542A (es)
CA (1) CA2304612A1 (es)
CO (1) CO4970816A1 (es)
CR (1) CR5926A (es)
CU (1) CU20000140A7 (es)
DE (1) DE69828442T2 (es)
DK (1) DK1045691T3 (es)
ES (1) ES2230733T3 (es)
GT (1) GT199800196A (es)
HN (1) HN1998000185A (es)
HU (1) HUP0004547A3 (es)
IL (1) IL135349A0 (es)
IS (1) IS2150B (es)
MY (1) MY118381A (es)
NO (1) NO20002966D0 (es)
NZ (1) NZ503982A (es)
PA (1) PA8464601A1 (es)
PE (1) PE20000017A1 (es)
PL (1) PL341066A1 (es)
PT (1) PT1045691E (es)
SV (1) SV1998000146A (es)
UY (1) UY25299A1 (es)
WO (1) WO1999030704A1 (es)
ZA (1) ZA9811348B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030105154A1 (en) 2001-10-24 2003-06-05 Bisgaier Charles Larry Statin-carboxyalkylether combinations
US6861555B2 (en) 2000-01-25 2005-03-01 Warner-Lambert Company Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith
WO1999030706A1 (en) * 1997-12-12 1999-06-24 Warner-Lambert Company ANTIHYPERLIPIDEMIC STATIN-LP(a) INHIBITOR COMBINATIONS
PL346980A1 (en) * 1998-09-30 2002-03-11 Warner Lambert Co Method for preventing or delaying catheter-based revascularization
US6562864B1 (en) * 1999-09-02 2003-05-13 Drake Larson Catechin multimers as therapeutic drug delivery agents
IN191580B (es) * 1999-12-17 2003-12-06 Ranbaxy Lab Ltd
JP4750995B2 (ja) 2000-01-25 2011-08-17 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー カルシウムジカルボキシレートエーテル、その製造法、及びそれを用いた血管系疾患及び糖尿病の治療
WO2001078747A1 (de) * 2000-04-18 2001-10-25 Bayer Aktiengesellschaft Verwendung von cse-hemmern zur behandlung von herzinsuffizienz
EA005245B1 (ru) * 2000-04-26 2004-12-30 Уорнер-Ламберт Компани Комбинация карбоксиалкиловых эфиров и гипотензивных агентов и фармацевтическое применение
US6689807B1 (en) * 2000-06-08 2004-02-10 Caritas St. Elizabeth's Medical Center Of Boston, Inc. HMG CoA reductase inhibitors for promoting angiogenesis
US6777552B2 (en) 2001-08-16 2004-08-17 Teva Pharmaceutical Industries, Ltd. Processes for preparing calcium salt forms of statins
CA2450820C (en) * 2001-08-16 2011-03-15 Teva Pharmaceutical Industries Ltd. Processes for preparing calcium salt forms of statins
US20050026979A1 (en) * 2003-07-31 2005-02-03 Maha Ghazzi Methods for treating inflammation and inflammation-associated diseases with a statin and ether
EP3735967A1 (en) 2012-01-06 2020-11-11 NeuroBo Pharmaceuticals, Inc. Compound for use in methods of reducing risk of cardiovascular disease
KR20180073665A (ko) 2015-11-06 2018-07-02 젬파이어 세러퓨틱스 인코포레이티드 심혈관 질환의 치료를 위한 젬카빈 조합

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648387A (en) * 1995-03-24 1997-07-15 Warner-Lambert Company Carboxyalkylethers, formulations, and treatment of vascular diseases

Also Published As

Publication number Publication date
DE69828442T2 (de) 2005-06-02
AU754089B2 (en) 2002-11-07
IL135349A0 (en) 2001-05-20
HUP0004547A3 (en) 2001-12-28
JP2002508320A (ja) 2002-03-19
SV1998000146A (es) 1999-09-30
AR017851A1 (es) 2001-10-24
MY118381A (en) 2004-10-30
DK1045691T3 (da) 2005-03-14
ATE285762T1 (de) 2005-01-15
HUP0004547A2 (hu) 2001-05-28
CU20000140A7 (es) 2005-10-19
KR20010033003A (ko) 2001-04-25
PT1045691E (pt) 2005-03-31
GT199800196A (es) 2000-06-03
CO4970816A1 (es) 2000-11-07
CA2304612A1 (en) 1999-06-24
NO20002966L (no) 2000-06-09
ES2230733T3 (es) 2005-05-01
IS5445A (is) 2000-04-14
EP1045691B1 (en) 2004-12-29
PE20000017A1 (es) 2000-01-20
BR9813542A (pt) 2000-10-10
UY25299A1 (es) 2001-08-27
EP1045691A1 (en) 2000-10-25
IS2150B (is) 2006-10-13
AU1591599A (en) 1999-07-05
NO20002966D0 (no) 2000-06-09
WO1999030704A1 (en) 1999-06-24
PA8464601A1 (es) 2001-12-14
PL341066A1 (en) 2001-03-26
NZ503982A (en) 2002-03-28
CR5926A (es) 2000-03-06
DE69828442D1 (de) 2005-02-03
ZA9811348B (en) 1999-06-14

Similar Documents

Publication Publication Date Title
HN1997000166A (es) 1-arilpirazoles plaguicidas
HN1998000086A (es) Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
HN1997000090A (es) Compuestos de piridilpirrol
HN1997000023A (es) Derivados de lactama
HN1998000132A (es) Combinaciones terapeuticas
HN1999000089A (es) Formulaciones de ziprasidona
HN1998000036A (es) Compuesto de pirazina
HN1998000011A (es) Derivados de acidos arilsulfonilaminohidroxamicos
ES2180899T3 (es) Dihidrato d de olanzapina.
HN1999000066A (es) Formulaciones farmaceuticas
HN1999000155A (es) 4-carboxiamino-2-metil-1,2,3,4-tetrahidroquinolinas
HN1997000146A (es) Derivados de pirimidina biciclica condensada
HN1998000124A (es) Terapia de combinacion
HN1998000185A (es) Combinaciones de estadina-eter carboxialquilico
HN1998003689A (es) Azetidinas
HN1998000030A (es) 2-amino-6-(4fenoxi-2-sustituido)-piridinas sustituidas
HN1998000158A (es) Isoquinolinas
HN1998000106A (es) Composiciones parenterales de alatroflaxacino
HN1998000028A (es) Otropisomeros de 3 heteroaril - 4 (3h) - quinazolinonas.
HN1998000199A (es) Agentes terapeuticos
HN1998000045A (es) Composiciones farmaceuticas
HN1998000193A (es) Compuestos de triazina
HN1998000102A (es) Composiciones solubilizadas de sertralina
HN1998000087A (es) Compuestos de amonio cuaternario
HN1999000008A (es) gen de streptomices